Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 322

1.

An open-label study of alefacept plus ultraviolet B light as combination therapy for chronic plaque psoriasis.

Ortonne JP, Khemis A, Koo JY, Choi J.

J Eur Acad Dermatol Venereol. 2005 Sep;19(5):556-63.

PMID:
16164708
4.

A randomized controlled study of combination therapy with alefacept and narrow band UVB phototherapy (UVB) for moderate to severe psoriasis: efficacy, onset, and duration of response.

Lui H, Gulliver W, Tan J, Hong CH, Hull P, Shear NH, Paradiso-Hardy F, Bissonette R.

J Drugs Dermatol. 2012 Aug;11(8):929-37.

PMID:
22859237
5.

A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis.

Krueger GG, Papp KA, Stough DB, Loven KH, Gulliver WP, Ellis CN; Alefacept Clinical Study Group.

J Am Acad Dermatol. 2002 Dec;47(6):821-33.

PMID:
12451365
6.
7.

An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis.

Lebwohl M, Christophers E, Langley R, Ortonne JP, Roberts J, Griffiths CE; Alefacept Clinical Study Group.

Arch Dermatol. 2003 Jun;139(6):719-27.

PMID:
12810502
8.

Synergism between narrowband ultraviolet B phototherapy and etanercept for the treatment of plaque-type psoriasis.

Calzavara-Pinton PG, Sala R, Arisi M, Rossi MT, Venturini M, Ortel B.

Br J Dermatol. 2013 Jul;169(1):130-6. doi: 10.1111/bjd.12277.

PMID:
23834117
9.

Systematic review of UV-based therapy for psoriasis.

Almutawa F, Alnomair N, Wang Y, Hamzavi I, Lim HW.

Am J Clin Dermatol. 2013 Apr;14(2):87-109. doi: 10.1007/s40257-013-0015-y. Review.

PMID:
23572293
10.

Clinical effectiveness and safety experience with alefacept in the treatment of patients with moderate-to-severe chronic plaque psoriasis in Taiwan: results of an open-label, single-arm, multicentre pilot study.

Huang PH, Liao YH, Wei CC, Tseng YH, Ho JC, Tsai TF.

J Eur Acad Dermatol Venereol. 2008 Aug;22(8):923-30. doi: 10.1111/j.1468-3083.2007.02575.x. Epub 2008 Feb 27.

PMID:
18312328
11.

Efficacy outcomes in patients using alefacept in the AWARE study.

Landells I, Searles G, Bissonnette R, Shear NH, Vender R, Lui H.

J Cutan Med Surg. 2009 Dec;13 Suppl 3:S122-30.

PMID:
20053324
12.

Narrowband UV-B phototherapy, alefacept, and clearance of psoriasis.

Legat FJ, Hofer A, Wackernagel A, Salmhofer W, Quehenberger F, Kerl H, Wolf P.

Arch Dermatol. 2007 Aug;143(8):1016-22.

PMID:
17709660
13.

Etanercept plus narrowband ultraviolet B phototherapy of psoriasis is more effective than etanercept monotherapy at 6 weeks.

Gambichler T, Tigges C, Scola N, Weber J, Skrygan M, Bechara FG, Altmeyer P, Kreuter A.

Br J Dermatol. 2011 Jun;164(6):1383-6. doi: 10.1111/j.1365-2133.2011.10358.x.

PMID:
21466532
14.

Alefacept: a novel biologic in the treatment of psoriasis.

Liu CM, McKenna JK, Krueger GG.

Drugs Today (Barc). 2004 Dec;40(12):961-74.

PMID:
15645008
15.

A multicenter, open-label study of repeat courses of intramuscular alefacept in combination with other psoriasis therapies in patients with chronic plaque psoriasis.

Krueger GG, Gottlieb AB, Sterry W, Korman N, Van De Kerkhof P.

J Dermatolog Treat. 2008;19(3):146-55. doi: 10.1080/09546630701846103.

PMID:
18569270
16.

Targeting T-cell subsets to achieve remission.

Christophers E.

J Eur Acad Dermatol Venereol. 2003 Jul;17 Suppl 2:6-11.

PMID:
12795769
17.

An extended 16-week course of alefacept in the treatment of chronic plaque psoriasis.

Gribetz CH, Blum R, Brady C, Cohen S, Lebwohl M.

J Am Acad Dermatol. 2005 Jul;53(1):73-5.

PMID:
15965424
18.

The AWARE study: methodology and baseline characteristics.

Bissonnette R, Searles G, Landells I, Shear NH, Papp K, Lui H, Gulliver WP, Lynde C.

J Cutan Med Surg. 2009 Dec;13 Suppl 3:S113-21.

PMID:
20053323
19.

A randomized, 'head-to-head' pilot study comparing the effects of etanercept monotherapy vs. etanercept and narrowband ultraviolet B (NB-UVB) phototherapy in obese psoriasis patients.

Park KK, Wu JJ, Koo J.

J Eur Acad Dermatol Venereol. 2013 Jul;27(7):899-906. doi: 10.1111/j.1468-3083.2012.04611.x. Epub 2012 Jun 15.

PMID:
22702846
20.

Update on alefacept safety.

Wexler D, Searles G, Landells I, Shear NH, Bissonnette R, Papp K, Poulin Y, Langley R, Gulliver WP.

J Cutan Med Surg. 2009 Dec;13 Suppl 3:S139-47.

PMID:
20053326
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk